Fu C - Search Results

1

A Novel Risk Factor for Para-Aortic Lymph Node Recurrence After Definite Pelvic Radiotherapy in Stage IIIB Cervical Cancer.

Zhang G, Wang C, Ma C, Miao L, He F, Fu C. Zhang G, et al. Among authors: fu c. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221141541. doi: 10.1177/15330338221141541. Technol Cancer Res Treat. 2022. PMID: 36426576 Free PMC article.

2

Adipocytokines and breast cancer risk.

Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, Sun Y, Wu Q, Chen L. Hou WK, et al. Chin Med J (Engl). 2007 Sep 20;120(18):1592-6. Chin Med J (Engl). 2007. PMID: 17908478

3

Adsorptive voltammetric determination of copper with a benzoin oxime graphite paste electrode.

Zhang G, Fu C. Zhang G, et al. Among authors: fu c. Talanta. 1991 Dec;38(12):1481-5. doi: 10.1016/0039-9140(91)80299-f. Talanta. 1991. PMID: 18965327

4

Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution.

Zhang G, Fu C, Zhang Y, Wang J, Qiao N, Yang Q, Cheng Y. Zhang G, et al. Among authors: fu c. Int J Gynecol Cancer. 2012 Sep;22(7):1220-5. doi: 10.1097/IGC.0b013e3182643b7c. Int J Gynecol Cancer. 2012. PMID: 22854654 Clinical Trial.

5

Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer.

Zhang G, He F, Fu C, Zhang Y, Yang Q, Wang J, Cheng Y. Zhang G, et al. Among authors: fu c. J Gynecol Oncol. 2014 Jan;25(1):14-21. doi: 10.3802/jgo.2014.25.1.14. Epub 2014 Jan 8. J Gynecol Oncol. 2014. PMID: 24459576 Free PMC article.

6

Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity.

Zhang G, He F, Miao L, Wu H, Zhang Y, Fu C. Zhang G, et al. Among authors: fu c. Jpn J Clin Oncol. 2021 May 28;51(6):905-910. doi: 10.1093/jjco/hyab047. Jpn J Clin Oncol. 2021. PMID: 33822980

7

Preoperative controlling nutritional status (CONUT) score is a prognostic factor for early-stage cervical cancer patients with high-risk factors.

Zhang G, Zhang Y, He F, Wu H, Wang C, Fu C. Zhang G, et al. Among authors: fu c. Gynecol Oncol. 2021 Sep;162(3):763-769. doi: 10.1016/j.ygyno.2021.06.012. Epub 2021 Jun 18. Gynecol Oncol. 2021. PMID: 34148719

8

Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy.

Zhang G, Miao L, Wu H, Zhang Y, Fu C. Zhang G, et al. Among authors: fu c. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211044626. doi: 10.1177/15330338211044626. Technol Cancer Res Treat. 2021. PMID: 34605696 Free PMC article.

9

The effectiveness of consolidation chemotherapy in high-risk early-stage cervical cancer patients following concurrent chemoradiation after radical surgery.

Wang C, Fu C, Ma C, Qian Q, He F, Zhang G. Wang C, et al. Among authors: fu c. Jpn J Clin Oncol. 2023 Jan 28;53(2):122-129. doi: 10.1093/jjco/hyac170. Jpn J Clin Oncol. 2023. PMID: 36408720

10

A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors.

Fu C, Wang C, Qian Q, Zhang Y, Ma C, Miao L, Zhang G. Fu C, et al. Gynecol Oncol Rep. 2023 Jun 15;48:101228. doi: 10.1016/j.gore.2023.101228. eCollection 2023 Aug. Gynecol Oncol Rep. 2023. PMID: 37389134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,077 results

Search Page

Filters